专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

81. 发明申请

WO2003071994A3 VARIABLE ARMABDUKTIONSORTHESE 审中-公开
公开(公告)号：WO2003071994A3
公开(公告)日：2003-09-04
申请号：PCT/EP2003/001926
申请日：2003-02-25
申请人： KLINIKUM DER UNIVERSITÄT REGENSBURG , BEHR, Karin
发明人： BEHR, Karin
IPC分类号： A61F5/37
摘要： Es wird eine Vorrichtung zur variablen Arm- bzw. Schulterlagerung zur Verfügung gestellt. Die erfindungsgemässe Vorrichtung kann insbesondere zur konservativen oder postoperativen Versorgung verschiedener Schulterverletzungen eingesetzt werden. Bevorzugt weist die Erfindung ein Distalelement (1), ein Proximalelement (2) sowie einen Achselkeil (3) auf, der bezüglich des Distalelements (1) und/oder des Proximalelements (2) zumindest höhenverstellbar ist. Bei einer weiteren erfindungsgemässen Ausführungsform ist das Distalelement bezüglich des Proximalelements zumindest winkelverstellbar und in einer dritten bevorzugten Ausführungsform sind sowohl Achselkeil als auch Distalelement verstellbar. Der Vorteil der Erfindung liegt in der variablen und unkomplizierten Einstellbarkeit der Orthese in Abhängigkeit von der Patientengrösse und der medizinischen Notwendigkeit.

82. 发明申请

WO2023057766A1 INFLUENZA VACCINES 审中-公开
公开(公告)号：WO2023057766A1
公开(公告)日：2023-04-13
申请号：PCT/GB2022/052534
申请日：2022-10-06
申请人： DIOSYNVAX LTD , THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE , UNIVERSITÄT REGENSBURG
发明人： HEENEY, Jonathan, Luke , VISHWANATH, Sneha , CARNELL, George , WELLS, David , FROST, Simon , FERRARI, Matteo , ASBACH, Benedikt , WAGNER, Ralf
IPC分类号： A61K39/12 , C07K14/005 , A61K2039/53 , C12N2760/16122 , C12N2760/16134
摘要： Polypeptides, nucleic acid molecules, vectors, cells, fusion proteins, pharmaceutical compositions, combined preparations, and their use as vaccines against influenza are described. The polypeptides comprise a haemagglutinin subtype 5 (H5) globular head domain, and optionally a haemagglutinin stem domain, wherein the polypeptide comprises an amino acid sequence in which an amino acid residue at a position corresponding to residue position 144 or 145 of a wild-type H5 globular head domain has been deleted, or wherein the polypeptide comprises an amino acid sequence with an E amino acid residue at a position corresponding to residue position 238 of a wild-type H5 globular head domain.

83. 发明申请

WO2022233920A1 DEVICE, TOOL AND SYSTEM FOR MINIMALLY INVASIVE ORBITAL FLOOR FRACTURE IMPLANTATION 审中-公开
公开(公告)号：WO2022233920A1
公开(公告)日：2022-11-10
申请号：PCT/EP2022/061947
申请日：2022-05-04
申请人： OSTBAYERISCHE TECHNISCHE HOCHSCHULE REGENSBURG , UNIVERSITÄTSKLINIKUM REGENSBURG , UNIVERSITÄT REGENSBURG
发明人： KÜHNEL, Thomas , BURGER, Moritz , SCHRATZENSTALLER, Thomas
IPC分类号： A61F2/28 , A61B17/80 , A61F2/46
摘要： The invention refers to an implant device (10) for treating an orbital floor fracture. The implant device (10) is foldable in a first direction between a folded state and an unfolded state and is plastically extendible in a second direction from an unextended state to an extended state. In the extended state, the implant device (10) has an extension in the second direction that is longer than a length in the unextended state and equal to or greater than an aperture distance of a human maxillary sinus in an anterior-posterior direction. The invention further refers to a related implantation tool, to a related implantation system for treating orbital blow fractures and to a corresponding implantation method.

84. 发明申请

WO2022136576A1 LIPOSOME-RECEPTOR-ASSAY FOR DETECTING NEUTRALIZING ANTIBODIES 审中-公开
公开(公告)号：WO2022136576A1
公开(公告)日：2022-06-30
申请号：PCT/EP2021/087352
申请日：2021-12-22
申请人： UNIVERSITÄT REGENSBURG
发明人： BÄUMNER, Antje , STEINER, Mark-Steven , PAULY, Diana , WAGNER, Ralf
IPC分类号： G01N33/543 , G01N33/569 , G01N33/58
摘要： The present invention relates to a particle collection for detecting a pathogen-neutralizing molecule. The present invention further relates to a composition comprising a particle collection. The present invention also relates to a method of detecting a pathogen- neutralizing molecule. Furthermore, the present invention relates to a kit for detecting a pathogen-neutralizing molecule. The present invention further relates to a point-of-care device, and to a use of a particle collection or a composition in a method of detecting a pathogen-neutralizing molecule.

85. 发明申请

WO2022112481A1 MICROEMULSION OR MICROSUSPENSION PROCESS FOR THE PRODUCTION OF A POLYMER DISPERSION, AND POLYMER PARTICLES OBTAINABLE BY THE PROCESS 审中-公开
公开(公告)号：WO2022112481A1
公开(公告)日：2022-06-02
申请号：PCT/EP2021/083117
申请日：2021-11-26
申请人： UNIVERSITÄT REGENSBURG
发明人： KUNZ, Werner , KRICKL, Sebastian , BLAHNIK, Jonas , SCHMID, Klaus
IPC分类号： C08F2/22 , C08F2/32 , C08F120/14 , C08F20/00
摘要： Provided is a process for the preparation of a polymer dispersion, comprising (a) a step of providing an oil-in-water microemulsion, which oil-in-water microemulsion comprises (i) dispersed domains comprising one or more types of radically polymerizable monomers which are insoluble in water or which have a miscibility gap with water, (ii) water, (iii) a hydrotrope which comprises a compound selected from compounds of the formula R1-(O-R2)m-O-R3 or of the formula R4-OH, or a mixture of two or more of these compounds, wherein R1 is a hydrocarbyl group which is free of any moiety with more than 6 carbon atoms attached to each other, m is 1 or 2, R2 is, independently for each occurrence if m is more than 1, selected from ethanediyl (-CH2-CH2-) and isopropanediyl (-CH(CH3)-CH2-), R3 is selected from hydrogen, methyl, ethyl, propyl, and -CH2-COOH, and R4 is a C3 to C6 alkyl group, and (iv) a radical initiator, and wherein, if the total amount of all radically polymerizable monomers in the oil-in-water microemulsion is 100 mol%, a molar ratio of the radically polymerizable monomers which are insoluble in water or which have a miscibility gap with water is 75 mol% to 100 mol%, and a molar ratio of other radically polymerizable monomers is 0 mol% to 25 mol%, and the oil-in-water microemulsion is substantially free of any surfactant selected from the group consisting of nonionic surfactants comprising a linear alkyl chain with more than 6 carbon atoms, cationic surfactants and anionic surfactants; and (b) a step of polymerizing the monomers comprised by the oil-in-water microemulsion to provide the polymer dispersion. Moreover, a polymer dispersion and polymer particles are provided which are obtainable by the process in accordance with the invention.

86. 发明申请

WO2022043136A1 VORRICHTUNG UND VERFAHREN ZUR DETEKTION VON EINEM WASSERTRANSPORT DURCH MINDESTENS EINE SCHICHT BIOLOGISCHER ZELLEN 审中-公开
公开(公告)号：WO2022043136A1
公开(公告)日：2022-03-03
申请号：PCT/EP2021/072849
申请日：2021-08-17
申请人： FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V. , UNIVERSITÄT REGENSBURG
发明人： HAJEK, Kathrin , WEGENER, Joachim , URBAN, Florian
IPC分类号： G01N33/483
摘要： Es wird eine Vorrichtung zur Detektion von einem Wassertransport durch bzw. über mindestens eine Schicht biologischer Zellen bereitgestellt, enthaltend einen ersten und zweiten Behälter, wobei der zweite Behälter zumindest teilweise innerhalb des ersten Behälters angeordnet ist, sodass zwei getrennte Kompartimente entstehen. Der Boden des zweiten Behälters besteht zumindest bereichsweise aus einem flächigen, wasserdurchlässigen Substrat zum Aufwachsen biologischer Zellen und der Boden des ersten Behälters weist ein Elektrodenpaar auf, dessen Elektroden jeweils eine elektrische Verbindung aufweisen, die in einen Raum außerhalb des ersten Behälters führt. Mit der erfindungsgemäßen Vorrichtung lässt sich ein Wassertransport über mindestens eine Schicht biologischer Zellen auf eine einfache, schnelle, robuste und reproduzierbare Art und Weise mit einer hohen zeitlichen Auflösung detektieren. Es wird zudem ein Verfahren zur Detektion von einem Wassertransport über mindestens eine Schicht biologischer Zellen vorgestellt.

87. 发明申请

WO2022013295A1 THE ROLE OF PMCIC IN THE TUMOR MICROENVIRONMENT 审中-公开
公开(公告)号：WO2022013295A1
公开(公告)日：2022-01-20
申请号：PCT/EP2021/069614
申请日：2021-07-14
申请人： UNIVERSITÄTSKLINIKUM REGENSBURG , UNIVERSITÄT REGENSBURG
发明人： HAFERKAMP, Sebastian , ADAMSKI, Jerzy , GEISSLER, Edward , MYCIELSKA, Maria , FEDERLIN, Marianne , MILENKOVIC, Vladimir , GAUMANN, Andreas , ZIEGLER, Christine , MADEJ, M. Gregor
IPC分类号： A61K31/192 , A61K31/194 , A61K31/40 , A61P35/00 , G01N33/574 , C12Q1/6886 , G01N33/68
摘要： The present invention relates to a pmCiC-inhibitor for use in a method of preventing or treating a tumor, wherein said inhibitor binds to pmCiCout on a tumor-associated stromal cell. The present invention further relates to a pharmaceutical composition for use in a method of preventing or treating a tumor, comprising a pmCiC inhibitor. The present invention also relates to a method of obtaining a prognosis of tumor progression.

88. 发明申请

WO2021198254A1 BIOCHANIN A DERIVATIVES FOR TREATMENT OF BEST1 -RELATED RETINOPATHIES 审中-公开
公开(公告)号：WO2021198254A1
公开(公告)日：2021-10-07
申请号：PCT/EP2021/058287
申请日：2021-03-30
申请人： UNIVERSITÄT REGENSBURG
发明人： WEBER, Bernhard , MILENKOVIC, Andrea , AMSLINGER, Sabine , DÜRR, Lisa Marie
IPC分类号： A61K31/352 , A61K9/00 , A61P27/02 , A61K9/0048 , A61K9/0051
摘要： The present invention refers to Biochanin A derivative as defined in formula (II) or a salt thereof for use in a method of treating or preventing BEST1-related retinopathies such as autosomal dominant Best vitelliform macular dystrophy. The present invention also refers to a pharmaceutical composition comprising a Biochanin A derivative as defined in formula (II) or a salt thereof and a pharmaceutical acceptable excipient and/or carrier for use in a method of treating or preventing BEST1-related retinopathies such as autosomal dominant Best vitelliform macular dystrophy. In addition, the present invention refers to a pharmaceutical pack comprising one or more compartments, wherein at least one compartment comprises a Biochanin A derivative as defined in formula (II) or a salt thereof or the pharmaceutical composition of the present invention for use according to the present invention or eye drops, an eye ointment or an implantable device, in particular a micro-drug delivery system, comprising (i) a Biochanin A derivative as defined in formula (II) or (ii) a pharmaceutical composition according to the present invention for use according to the present invention.

89. 发明申请

WO2020200985A1 TRANSURETHRAL CATHETER DEVICE FOR BLEEDING CONTROL IN PELVIC FRACTURES 审中-公开
公开(公告)号：WO2020200985A1
公开(公告)日：2020-10-08
申请号：PCT/EP2020/058458
申请日：2020-03-26
申请人： UNIVERSITÄT REGENSBURG - UNIVERSITÄTSKLINIKUM
发明人： KERSCHBAUM, Maximilian
IPC分类号： A61M25/10 , A61B17/12 , A61F2/00
摘要： The inventions relates to a transurethral catheter device for bleeding control in pelvic fractures. The catheter device comprises an expandable body assembly with at least one expandable body. The expandable body assembly comprises a proximal portion, a center portion and a distal portion. The expandable body assembly is configured to be expanded from a collapsed state to an expanded state by expanding the at least one expandable body. The expandable body assembly is further configured to be inserted into the urinary bladder of a patient via the urethra in the collapsed state. In the expanded state, the proximal portion has a length l 1 and a width w 1 , the center portion a length l 2 and a width w 2 , the distal portion a length l 3 and a width w 3 , and the expandable body assembly a total length l. A displacement volume V of the expandable body assembly in the expanded state is larger than 0.5 liters. The width w 2 is smaller than 50% of the width w 3 . The width w 1 is larger than a width w 1 of the proximal portion in the collapsed state and the width w 3 is larger than a width w 3 of the distal portion in the collapsed state. The length l 1 is smaller than 25 % of the total length l. This allows for arranging the expandable body assembly in the expanded state in the urinary bladder such that the proximal portion is adjacent to the internal urethral orifice of the urinary bladder and the center portion is adjacent to the ureter orifices of the urinary bladder, but not in contact with the ureter orifices.

90. 发明申请

WO2018015884A1 ON-CHIP GRAPHENE ELECTRODE, METHODS OF MAKING, AND METHODS OF USE 审中-公开
标题翻译：片上石墨电极，制备方法和使用方法
公开(公告)号：WO2018015884A1
公开(公告)日：2018-01-25
申请号：PCT/IB2017/054337
申请日：2017-07-18
申请人： KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY , UNIVERSITÄT REGENSBURG
发明人： NAYAK, Pranati , ALSHAREEF, Husam Niman , BAEUMNER, Antje J. , DUERKOP, Axel , FENZL, Christoph , HIRSCH, Thomas
IPC分类号： G01N27/327 , G01N33/50
摘要： Embodiments of the present disclosure provide a device including an on-chip electrode platform including one or more three dimensional laser scribed graphene electrodes, methods of making the on-chip electrode platform, methods of analyzing (e.g., detecting, quantifying, and the like) chemicals and biochemicals, and the like.
摘要翻译：本公开的实施例提供了一种装置，该装置包括包含一个或多个三维激光划片的石墨烯电极的芯片上电极平台，制造芯片上电极平台的方法，分析方法（例如，检测，定量等），化学品和生物化学品等。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式